Table 2 Correlation of the total simplified Mastora score with clinical features, laboratory, and imaging findings

Age

0.03 (-0.19–0.25)

0.78

-0.06 (-0.34–0.23)

0.70

Wells score

0.07 (-0.15–0.28)

0.51

-0.01 (-0.29–0.28)

0.97

PESI score

0.03 (-0.19–0.24)

0.82

0.04 (-0.25–0.32)

0.79

PAP (mmHg)

0.54 (0.21–0.76)

0.002

0.65 (0.24–0.87)

0.004

Tricuspid valve regurgitation grade

0.40 (0.02–0.68)

0.034

0.44 (-0.07–0.77)

0.080

D-dimer (mg/L)

0.30 (0.07–0.50)

0.011

0.19 (-0.15–0.49)

0.26

Troponin (ng/L)

0.32 (0.09–0.51)

0.005

0.27 (-0.05–0.55)

0.087

BNP (ng/L)

0.26 (-0.22–0.64)

0.005

0.37 (-0.65–0.92)

0.47

NLR

-0.09 (-0.32–0.14)

0.43

-0.06 (-0.37–0.26)

0.69

Lymphocytes (/µL)

-0.01 (-0.23–0.22)

0.97

0.02 (-0.29–0.33)

0.90

CRP (mg/L)

-0.02 (-0.25–0.22)

0.88

0.14 (-0.19–0.44)

0.38

Procalcitonin (µg/L)

0.09 (-0.16–0.32)

0.47

0.16 (-0.17–0.47)

0.33

Interleukin-6 (pg/ml)

0.07 (-0.36–0.47)

0.75

0.10 (-0.49–0.63)

0.74

Systolic blood pressure

-0.03 (-0.27–0.21)

0.80

0.02 (-0.30–0.34)

0.89

Pulse oximetry-derived oxygen saturation

0.19 (-0.07–0.42)

0.14

0.11 (-0.23–0.43)

0.52

MPA diameter (mm)

0.22 (0.01–0.42)

0.041

0.23 (-0.07–0.48)

0.12

RPA diameter (mm)

0.10 (-0.12–0.31)

0.37

0.12 (-0.17–0.39)

0.42

LPA diameter (mm)

0.20 (-0.01–0.40)

0.058

0.21 (-0.07–0.47)

0.14

Ascending aorta diameter (mm)

0.09 (-0.13–0.30)

0.44

0.02 (-0.27–0.30)

0.92

SVC diameter (mm)

0.11 (-0.11–0.32)

0.30

-0.01 (-0.29–0.28)

0.96

MPA/ascending aorta ratio

0.12 (-0.10–0.33)

0.25

0.16 (-0.13–0.43)

0.25

RV/LV ratio

0.26 (0.05–0.46)

0.015

0.24 (-0.06–0.50)

0.10

Median total Mastora score (IQR)

p-value

Median total Mastora score (IQR)

p-value

Gender

0.51

0.63

Male

16.5 (15.0)

14.0 (21.0)

Female

18.0 (34.0)

11.0 (34.0)

Presence of comorbidity

17.0 (22.0)

0.62

11.0 (23.0)

0.50

No comorbidity

15.5 (18.0)

15.5 (19.0)

Diagnosed with SARS-CoV-2 PCR

13.0 (23.0)

0.054

13.5 (23.0)

0.30

Diagnosed with thoracic CT

18.0 (30.0)

20.0 (24.0)

Pneumonia

17.0 (19.0)

0.50

15.0 (22.0)

0.40

Mild disease

12.0 (34.0)

6.0 (36.0)

Patients with DVT

20.5 (28.0)

0.013

27.0 (36.0)

0.023

Patients without DVT

13.0 (22.0)

12.0 (20.0)

Severe COVID-19

9.0 (25.0)

0.32

9.0 (43.0)

0.59

Non-severe COVID-19

17.0 (21.0)

18.0 (20.0)

Early mortality risk

0.002

0.009

Low

11.0 (17.0)*

11.0 (18.0)*

Intermediate-low

18.5 (18.0)

23.0 (28.0)

Intermediate-high/high

31.5 (25.0)*

39.0 (19.0)*